Literature DB >> 15528069

A Monte Carlo brachytherapy study for dose distribution prediction in an inhomogeneous medium.

Lawrence J Slate1, Howard R Elson, Michael A S Lamba, William M Kassing, Michael Soldano, William L Barrett.   

Abstract

The purpose of this study was to present a theoretical analysis of how the presence of bone in interstitial brachytherapy affects dose rate distributions. This study was carried out using a Monte Carlo simulation of the dose distribution in homogeneous medium for 3 commonly used brachytherapy seeds. The 3 seeds investigated in this study are iridium-192 (192Ir) iodine-125 (125I), and palladium-103 (103Pd). The computer code was validated by comparing the specific dose rate (Lambda), the radial dose function g(r), and anisotropy function F(r,theta;) for all 3 seeds with the AAPM TG-43 dosimetry formalism and current literature. The 192Ir seed resulted in a dose rate of 1.115 +/- 0.001 cGy-hr(-1)-U(-1), the 125I seed resulted in a dose rate of 0.965 +/- 0.006 cGy/h(-1)/U(-1), and the 103Pd seed resulted in a dose rate of 0.671 +/- 0.002 cGy/h(-1)/U(-1). The results for all 3 seeds are in good agreement with the AAPM TG-43 and current literature. The validated computer code was then applied to a simple inhomogeneous model to determine the effect bone has on dose distribution from an interstitial implant. The inhomogeneous model showed a decrease in dose rate of 2% for the 192Ir, an increase in dose rate of 84% for 125I, and an increase in dose rate of 83% for the 103Pd at the surface of the bone nearest to the source.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528069     DOI: 10.1016/j.meddos.2004.02.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  1 in total

1.  Determination of dosimetric parameters for shielded 153Gd source in prostate cancer brachytherapy.

Authors:  Mahdi Ghorbani; Benyamin Khajetash; Najmeh Ghatei; Mohammad Mehrpouyan; Ali S Meigooni; Ramin Shahraini
Journal:  Radiol Oncol       Date:  2017-02-22       Impact factor: 2.991

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.